Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation

Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 2022-10, Vol.933, p.175291-175291, Article 175291
Hauptverfasser: Zhang, Zhi-Tong, He, Wen-Jiao, Deng, Si-Min, Xu, Shu-Hong, Zeng, Xia, Qian, Zheng-Ming, Chen, Zhi-Quan, Wang, Shu-Mei, Tang, Dan
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 175291
container_issue
container_start_page 175291
container_title European journal of pharmacology
container_volume 933
creator Zhang, Zhi-Tong
He, Wen-Jiao
Deng, Si-Min
Xu, Shu-Hong
Zeng, Xia
Qian, Zheng-Ming
Chen, Zhi-Quan
Wang, Shu-Mei
Tang, Dan
description
doi_str_mv 10.1016/j.ejphar.2022.175291
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2717691025</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2717691025</sourcerecordid><originalsourceid>FETCH-LOGICAL-c284t-b2d7e33f402592807b0007805eb33ad664c25aea97c8060fbf83e74439809f83</originalsourceid><addsrcrecordid>eNotkc-KFDEQh4MoOK6-gYccvfSYpP-kc5RFXWFwF5l7qE5X72RId9pUemB8GV_VLOOpiqofH1V8jH2UYi-F7D6f93heT5D2Sii1l7pVRr5iO9lrUwkt1Wu2E0I2lTLGvGXviM5CiNaodsf-HpMPcYDsFw4h4MVDRuJLXCoILp5i8I5PkPOVB3_BxEdPCIS85E_--VSVXZlh5mvYiFNOuOb4J-bo_FL5ZdwcjiUAA-ZCmr1DPlw5beuakMgvz_zn4ddTXXhTgHkGijNycNlfyk1xec_eTBAIP_yvd-z47evx_qE6PH7_cf_lUDnVN7ka1KixrqdGqPJXL_RQPtS9aHGoaxi7rnGqBQSjXS86MQ1TX6Numtr0wpT-jn26YdcUf29I2c6eHIYAC8aNrNJSd0YWeok2t6hLkSjhZNfkZ0hXK4V90WHP9qbDvuiwNx31P6itg8A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2717691025</pqid></control><display><type>article</type><title>Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation</title><source>Elsevier ScienceDirect Journals</source><creator>Zhang, Zhi-Tong ; He, Wen-Jiao ; Deng, Si-Min ; Xu, Shu-Hong ; Zeng, Xia ; Qian, Zheng-Ming ; Chen, Zhi-Quan ; Wang, Shu-Mei ; Tang, Dan</creator><creatorcontrib>Zhang, Zhi-Tong ; He, Wen-Jiao ; Deng, Si-Min ; Xu, Shu-Hong ; Zeng, Xia ; Qian, Zheng-Ming ; Chen, Zhi-Quan ; Wang, Shu-Mei ; Tang, Dan</creatorcontrib><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2022.175291</identifier><language>eng</language><ispartof>European journal of pharmacology, 2022-10, Vol.933, p.175291-175291, Article 175291</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c284t-b2d7e33f402592807b0007805eb33ad664c25aea97c8060fbf83e74439809f83</citedby><cites>FETCH-LOGICAL-c284t-b2d7e33f402592807b0007805eb33ad664c25aea97c8060fbf83e74439809f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Zhang, Zhi-Tong</creatorcontrib><creatorcontrib>He, Wen-Jiao</creatorcontrib><creatorcontrib>Deng, Si-Min</creatorcontrib><creatorcontrib>Xu, Shu-Hong</creatorcontrib><creatorcontrib>Zeng, Xia</creatorcontrib><creatorcontrib>Qian, Zheng-Ming</creatorcontrib><creatorcontrib>Chen, Zhi-Quan</creatorcontrib><creatorcontrib>Wang, Shu-Mei</creatorcontrib><creatorcontrib>Tang, Dan</creatorcontrib><title>Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation</title><title>European journal of pharmacology</title><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNotkc-KFDEQh4MoOK6-gYccvfSYpP-kc5RFXWFwF5l7qE5X72RId9pUemB8GV_VLOOpiqofH1V8jH2UYi-F7D6f93heT5D2Sii1l7pVRr5iO9lrUwkt1Wu2E0I2lTLGvGXviM5CiNaodsf-HpMPcYDsFw4h4MVDRuJLXCoILp5i8I5PkPOVB3_BxEdPCIS85E_--VSVXZlh5mvYiFNOuOb4J-bo_FL5ZdwcjiUAA-ZCmr1DPlw5beuakMgvz_zn4ddTXXhTgHkGijNycNlfyk1xec_eTBAIP_yvd-z47evx_qE6PH7_cf_lUDnVN7ka1KixrqdGqPJXL_RQPtS9aHGoaxi7rnGqBQSjXS86MQ1TX6Numtr0wpT-jn26YdcUf29I2c6eHIYAC8aNrNJSd0YWeok2t6hLkSjhZNfkZ0hXK4V90WHP9qbDvuiwNx31P6itg8A</recordid><startdate>20221015</startdate><enddate>20221015</enddate><creator>Zhang, Zhi-Tong</creator><creator>He, Wen-Jiao</creator><creator>Deng, Si-Min</creator><creator>Xu, Shu-Hong</creator><creator>Zeng, Xia</creator><creator>Qian, Zheng-Ming</creator><creator>Chen, Zhi-Quan</creator><creator>Wang, Shu-Mei</creator><creator>Tang, Dan</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20221015</creationdate><title>Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation</title><author>Zhang, Zhi-Tong ; He, Wen-Jiao ; Deng, Si-Min ; Xu, Shu-Hong ; Zeng, Xia ; Qian, Zheng-Ming ; Chen, Zhi-Quan ; Wang, Shu-Mei ; Tang, Dan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c284t-b2d7e33f402592807b0007805eb33ad664c25aea97c8060fbf83e74439809f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Zhi-Tong</creatorcontrib><creatorcontrib>He, Wen-Jiao</creatorcontrib><creatorcontrib>Deng, Si-Min</creatorcontrib><creatorcontrib>Xu, Shu-Hong</creatorcontrib><creatorcontrib>Zeng, Xia</creatorcontrib><creatorcontrib>Qian, Zheng-Ming</creatorcontrib><creatorcontrib>Chen, Zhi-Quan</creatorcontrib><creatorcontrib>Wang, Shu-Mei</creatorcontrib><creatorcontrib>Tang, Dan</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Zhi-Tong</au><au>He, Wen-Jiao</au><au>Deng, Si-Min</au><au>Xu, Shu-Hong</au><au>Zeng, Xia</au><au>Qian, Zheng-Ming</au><au>Chen, Zhi-Quan</au><au>Wang, Shu-Mei</au><au>Tang, Dan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation</atitle><jtitle>European journal of pharmacology</jtitle><date>2022-10-15</date><risdate>2022</risdate><volume>933</volume><spage>175291</spage><epage>175291</epage><pages>175291-175291</pages><artnum>175291</artnum><issn>0014-2999</issn><eissn>1879-0712</eissn><doi>10.1016/j.ejphar.2022.175291</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 2022-10, Vol.933, p.175291-175291, Article 175291
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_2717691025
source Elsevier ScienceDirect Journals
title Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A15%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trilobatin%20alleviates%20non-alcoholic%20fatty%20liver%20disease%20in%20high-fat%20diet%20plus%20streptozotocin-induced%20diabetic%20mice%20by%20suppressing%20NLRP3%20inflammasome%20activation&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Zhang,%20Zhi-Tong&rft.date=2022-10-15&rft.volume=933&rft.spage=175291&rft.epage=175291&rft.pages=175291-175291&rft.artnum=175291&rft.issn=0014-2999&rft.eissn=1879-0712&rft_id=info:doi/10.1016/j.ejphar.2022.175291&rft_dat=%3Cproquest_cross%3E2717691025%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2717691025&rft_id=info:pmid/&rfr_iscdi=true